These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12422668)

  • 41. New insights into the regulation of HDL metabolism and reverse cholesterol transport.
    Lewis GF; Rader DJ
    Circ Res; 2005 Jun; 96(12):1221-32. PubMed ID: 15976321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport.
    Oliver WR; Shenk JL; Snaith MR; Russell CS; Plunket KD; Bodkin NL; Lewis MC; Winegar DA; Sznaidman ML; Lambert MH; Xu HE; Sternbach DD; Kliewer SA; Hansen BC; Willson TM
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5306-11. PubMed ID: 11309497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoproteins.
    Argmann CA; Sawyez CG; McNeil CJ; Hegele RA; Huff MW
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):475-82. PubMed ID: 12615696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis.
    Lund EG; Menke JG; Sparrow CP
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1169-77. PubMed ID: 12615685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolism.
    Fruchart JC
    Am J Cardiol; 2001 Dec; 88(12A):24N-29N. PubMed ID: 11788127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tangier disease as a test of the reverse cholesterol transport hypothesis.
    Tall AR; Wang N
    J Clin Invest; 2000 Nov; 106(10):1205-7. PubMed ID: 11086021
    [No Abstract]   [Full Text] [Related]  

  • 47. Polarized cholesterol and phospholipid efflux in cultured gall-bladder epithelial cells: evidence for an ABCA1-mediated pathway.
    Lee J; Shirk A; Oram JF; Lee SP; Kuver R
    Biochem J; 2002 Jun; 364(Pt 2):475-84. PubMed ID: 12023891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine.
    Yin K; You Y; Swier V; Tang L; Radwan MM; Pandya AN; Agrawal DK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2432-42. PubMed ID: 26381871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atherosclerosis: cell biology and lipoproteins.
    Daugherty A; Rateri DL
    Curr Opin Lipidol; 2008 Jun; 19(3):328-9. PubMed ID: 18460928
    [No Abstract]   [Full Text] [Related]  

  • 50. ABCA1: regulation, function and relationship to atherosclerosis.
    Francone OL; Aiello RJ
    Curr Opin Investig Drugs; 2002 Mar; 3(3):415-9. PubMed ID: 12054089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cholesteryl ester transfer protein.
    Lancet; 1991 Sep; 338(8768):666-7. PubMed ID: 1679480
    [No Abstract]   [Full Text] [Related]  

  • 52. Associations between common genetic polymorphisms in the liver X receptor alpha and its target genes with the serum HDL-cholesterol concentration in adolescents of the HELENA Study.
    Legry V; Bokor S; Beghin L; Galfo M; Gonzalez-Gross M; Molnar D; Moreno LA; Amouyel P; Dallongeville J; Meirhaeghe A;
    Atherosclerosis; 2011 May; 216(1):166-9. PubMed ID: 21316679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of the expression of key genes involved in HDL metabolism by unsaturated fatty acids.
    Kuang YL; Paulson KE; Lichtenstein AH; Lamon-Fava S
    Br J Nutr; 2012 Oct; 108(8):1351-9. PubMed ID: 22221450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Molecular mechanism of reverse cholesterol transport].
    Miida T
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():463-7. PubMed ID: 11351631
    [No Abstract]   [Full Text] [Related]  

  • 55. High-density lipoprotein cholesterol: a potential therapeutic target for prevention of coronary artery disease.
    Chernobelsky A; Ashen MD; Blumenthal RS; Coplan NL
    Prev Cardiol; 2007; 10(1):26-30. PubMed ID: 17215630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter in response to recent paper by Fournier et al.
    Dullaart RP; van Tol A
    Atherosclerosis; 2002 Oct; 164(2):379-80. PubMed ID: 12204811
    [No Abstract]   [Full Text] [Related]  

  • 57. Reconstitution of flippase activity into liposomes.
    Devaux PF
    Cell Mol Biol Lett; 2002; 7(2):227-9. PubMed ID: 12097926
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficacy of cholesterol ester transfer protein inhibitors in prevention of atherosclerosis.
    Kinoshita M
    Curr Atheroscler Rep; 2004 Mar; 6(2):79-80. PubMed ID: 15023288
    [No Abstract]   [Full Text] [Related]  

  • 59. Down with the bad, up with the good. A biotech firm develops a vaccine to raise good cholesterol levels.
    Maeder T
    Sci Am; 2002 Feb; 286(2):32-3. PubMed ID: 11828696
    [No Abstract]   [Full Text] [Related]  

  • 60. Nuclear receptors and microRNA-144 coordinately regulate cholesterol efflux.
    Vickers KC; Rader DJ
    Circ Res; 2013 Jun; 112(12):1529-31. PubMed ID: 23743223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.